Derazantinib (ARQ 087) in Advanced or Inoperable FGFR2 Gene Fusion-Positive Intrahepatic Cholangiocarcinoma
British Journal of Cancer - United Kingdom
doi 10.1038/s41416-018-0334-0
Full Text
Open PDFAbstract
Available in full text
Date
November 13, 2018
Authors
Publisher
Springer Science and Business Media LLC